Two studies published recently in the Proceedings of the National Academy of Sciences, led by researchers at the Icahn School of Medicine at Mount Sinai, demonstrate how widely used, inexpensive medications to treat osteoporosis, known as bisphosphonates, have the potential to become potent cancer-fighting drugs. Read more
When Ann Ogden was first diagnosed with kidney cancer in 2001, she had no idea that creating a cooking network for cancer patients would someday become her great life’s work. Ann was, professionally, a fashion designer, but she found her culinary knowledge to be particularly useful while managing the side effects of treatment for a later diagnosed breast cancer. She would swap recipes with other patients, who found her guidance helpful and encouraged her to do more with her skills. In 2007, Cook for Your Life–a website dedicated to providing healthy recipes, cooking tips and nutrition information to cancer survivors–was born. Read more
Charles L. Shapiro, MD, a renowned breast cancer researcher and clinician, has been named Co-Director of the Dubin Breast Center, Director of Translational Breast Cancer Research for the Mount Sinai Health System, and Director of Survivorship Programs at The Tisch Cancer Institute at Mount Sinai.
“As a nationally recognized leader in breast medical oncology and research, Dr. Shapiro will have a pivotal role in advancing breast cancer treatment and care for our patients,” says Elisa Port, MD, Chief of Breast Surgery and Co-Director of the Dubin Breast Center at The Tisch Cancer Institute.
Blending or juicing fruit and vegetables has become incredibly popular for people hoping to improve their health, not without good reason. When attempting to consume a diet that is based in plant-foods, drinks made of these things can serve as an appropriate quick fix.
Breast Cancer Awareness Month comes to us in October, a time when the cooling weather and change in seasonal produce lead us to reach for our favorite fall comfort foods. Spiced ciders, doughnuts, and pumpkin everything are a few of the season’s best indulgences, but as indulgences they should remain, or we’ll find ourselves entering the holidays with bloated stomachs and ill-fitting clothes.
Two newly identified proteins that appear to play a critical role in the development of aggressive triple-negative breast cancer (TNBC) could also lead to potential new treatments, according to scientists at Icahn School of Medicine at Mount Sinai, the University of Kentucky, MD Anderson Cancer Center, and several medical centers in China.
Allium vegetables comprise approximately 500 species, the most common including onions, leeks, garlic, chives, and shallots. They have been valued throughout history for their flavor as well as their medicinal properties. Rich in health-promoting flavanols and organosulfur compounds, alliums have increasingly attracted the interest of the medical community for their potential to play a part in preventing cancer.
According to the American Institute for Cancer Research, about one third of cancers in high-income countries can be attributed to preventable factors such as nutrition and physical activity. In the United States, breast cancer is the most commonly diagnosed cancer in women, astoundingly impacting one in every eight women in their lifetimes.
At this time, we don’t know exactly why many women develop breast cancer, but the following tips from the Dubin Breast Center’s Clinical Nutrition Coordinator Alexandra Rothwell, RD, can help to reduce your risk for cancer and may help to prevent recurrence among cancer survivors.
Hospital and community leaders, local legislators, and residents of Western Queens gathered on Monday, October 21, to break ground on a $125 million expansion project at Mount Sinai Queens, which will enhance emergency and outpatient care, and diagnostic and laboratory services, when it is completed in 2016.
Personalized Medicine is a rapidly evolving approach to patient care that incorporates an individual’s genetic information into a customized prevention or treatment plan. Mapping a person’s total genetic makeup or whole genome sequencing has created mountains of data about variations in our human genetic code. As this experience has grown, some of these variations have been linked to risks for certain diseases, or in some cases the likelihood that a person will respond to a particular treatment. Individuals may now submit a DNA sample and obtain their genetic sequence with accompanying risk association analysis for a few hundred dollars. Can this technology however be harnessed to drive better outcomes for patients diagnosed with cancer? Many clinicians and scientists argue that we are not there yet.